April 2 -- WEDNESDAY, April 2 (HealthDay News) -- A topical cream appears to be a highly effective treatment for precancerous lesions on the vulva, Dutch researchers report. Rather than directly ...

Women vaccinated against HPV had a 37% lower risk of developing high-grade vulvovaginal lesions compared with unvaccinated ...

Nov. 5 -- WEDNESDAY, Nov. 4 (HealthDay News) -- A vaccine that targets human papillomavirus (HPV) is able to stop precancerous lesions in the vulva from progressing into full-blown malignancies, Dutch ...

Girls who are vaccinated against HPV are not only well protected against cervical cancer; they are also less likely to develop severe precancerous lesions of the vulva and vagina, particularly if they ...

The Human papillomavirus (HPV) vaccine, known for preventing cervical cancer, can also help safeguard against precancerous lesions of the vulva and vagina in girls and women, according to a study.

(MENAFN- IANS) New Delhi, Dec 20 (IANS) The Human papillomavirus (HPV) vaccine, known for preventing cervical cancer, can also help safeguard against precancerous lesions of the vulva and vagina in ...

Vulvar cancer is a rare type of cancer that affects your vulva. Several options, such as topical medication, surgery, and chemotherapy, are available to treat cancerous and precancerous cells near ...

Doctors give vulvar cancer diagnoses with a stage and grade. They determine the stage and grade by looking at the location, size, and spread of the cancer. Vulvar cancer, also known as vulval cancer ...

Girls who are vaccinated against HPV are not only well protected against cervical cancer; they are also less likely to develop severe precancerous lesions of the vulva and vagina, particularly if they ...

Vulvar cancer tends to be slow growing, progressing over several years. But some less common types can spread to other parts of your body faster. The current 5-year relative survival rate, which is ...